Industry Satellite Symposia

Thursday, March 14
6:00 p.m. - 8:00 p.m.
Aqua Salons DE (Level 3/Aqua Level)
Registration and dinner open at 6:00 p.m.
To register or learn more, visit PeerView.com/MTC19CPI.
 
The Present and Future of Immunotherapy as a Key Component of the Treatment Arsenal for Locally Advanced and Earlier Stages of Lung Cancer: State of the Science, Practicalities and Implications for Multidisciplinary Patient Care

Key Reasons to Attend

  • Get the latest insights on how to incorporate immunotherapy into multimodal treatment regimens to optimize treatment outcomes for patients with stage III, unresectable NSCLC.
  • Learn best practices for multidisciplinary collaboration and coordination of care in management of patients with NSCLC during the immunotherapy era.
  • Hear about immunotherapeutic strategies and combinations being explored in neoadjuvant and adjuvant trials in earlier stages of lung cancer

This CME/MOC/CNE activity is jointly provided by Medical Learning Institute Inc. and PVI, PeerView Institute for Medical Education.

This activity is supported by an independent educational grant from AstraZeneca.


Friday, March 15, 2019
4:45 p.m. - 6:45 p.m.
Aqua Salons DE (Level 3/Aqua Level)
Registration and dinner open at 4:45 p.m.
To register or learn more, visit PeerView.com/MTC19EGFR.

Refining Current Practice and Exploring New Frontiers in EGFR-Mutant NSCLC: Evolving Science, New Standards of Care and Implications for Multidisciplinary Management

Key Reasons to Attend

  • Hear about the latest data that has shifted the standard of care in the first-line management of patients with EGFR-mutated NSCLC.
  • Explore the mechanisms of acquired resistance that may develop when third-generation EGFR TKI therapy is used in the front-line setting, and learn about strategies that are showing promise to address these resistance mechanisms.
  • Learn more about the practicalities of using a multidisciplinary approach to managing patients with EGFR-mutant NSCLC.

This CME/MOC/CNE activity is jointly provided by Medical Learning Institute Inc. and PVI, PeerView Institute for Medical Education.

This activity is supported by an independent educational grant from AstraZeneca.

Copyright © 2019 American Society for Radiation Oncology | Conflict of Interest | Terms of Use | Privacy Policy | Contact Us 
251 18th Street South, 8th Floor, Arlington, VA 22202 | Phone: 703.502.1550 | Fax: 703.502.7852